The Hematological Deterioration and its Influences to the Human Body During Cardiopulmonary Bypass

体外循环过程中血液学恶化及其对人体的影响

基本信息

  • 批准号:
    01480340
  • 负责人:
  • 金额:
    $ 4.35万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1990
  • 项目状态:
    已结题

项目摘要

The study is composed of the injury and reactions by each blood components such as leukocyte, platelet, coagulant factors, complement and other serum active proteins during cardiopulmonary bypass.Following data was obtained form clinical cardiopulmonary bypass in our hospital and experimental mock circulation with artificial lung.1. Accession of coagulation cascade and consumption of each coagulant factors were observed and finally thrombin-antithrombin III complex increased in circulating blood after clinical cardiopulmonary bypass. Activation of kininogen and prekalikrein followed by decreasing fibrinogen in mock circuits with normal temperature.2. Fibrinolytic process with increased plasmin-d_2plasmin inhibitor complex was always observed in clinical cardiopulmonary bypass circulation, otherwise, mild fibrinolysis occurred in mock circulation.3. The platelet counts decreased immediately after cardiopulmonary bypass in both clinical and experimental circulation and subsequent increasing possibly due to mobilization from pooled platelets in clinical circulation.platelet aggregation activity was strongly suppressed in both circulation and need several days to get normal activity in clinical cases.4. Polymorphonuclear leukocyte counts initially decreased during the hypothermic anoxic arrest and markedly increased after rewarming. Serum levels of neutrophil elastase significantly rose during CPB and superoxide anion was more generated after CPB.5. Both complement factor 4 and 3 were activated during CPB under following circumstances ex. hypothermia or normothermia, in clinical or mock circuits.Some drugs would be applied to diminish the hematological change and influence to the human body.
本研究包括体外循环期间血液中白细胞、血小板、凝血因子、补体等血液成分的损伤和反应。以下数据来自本院临床体外循环和人工肺模拟循环实验。观察凝血级联的增加和各凝血因子的消耗,最终使体外循环后循环血中凝血酶-抗凝血酶III复合体增加。结论:1.在常温模拟回路中,激肽原和前激肽释放酶激活,纤维蛋白原降低。临床体外循环中可见纤溶酶-D_2纤溶酶抑制物复合体增多的纤溶过程,而模拟循环可见轻度纤溶作用。临床和实验循环中的血小板计数在体外循环后即刻下降,随后可能由于临床循环中聚集的血小板的动员而升高,两种循环中的血小板聚集活性都受到强烈的抑制,临床病例需要数天时间才能恢复正常活动。中性粒细胞计数在低温缺氧停搏时最初下降,复温后显著升高。CPB期间血清中性粒细胞弹性蛋白酶水平明显升高,CPB后超氧阴离子生成增多。在CPB期间,补体4和补体3在以下情况下均被激活。低温或常温,在临床或模拟电路中。一些药物可用于减轻血液系统的变化和对人体的影响。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K Togashi et al: "The effect of blood transfusion upon the immune response in the early phase of the patients underwent open heart surgery" Jpn J Thorac Cardiovasc Surg. 36 :. 448-453, (1988)
K Togashi 等人:“输血对接受心脏直视手术的患者早期免疫反应的影响”Jpn J Thorac Cardiovasc Surg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
富樫賢一: "開心術時の放射線照射血輸血が細胞性免疫反応に及ぼす影響" 日本胸部外科学会雑誌. 37. 1958-1964 (1989)
Kenichi Togashi:“心脏直视手术期间辐照输血对细胞免疫反应的影响”日本胸外科学会杂志 37。1958-1964(1989)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K Togashi et al: "Complement activation during cardiopulmonary bypass : mechanism and prevention" Kyobu Geka. 42 :. 529-532, (1989)
K Togashi 等人:“体外循环期间的补体激活:机制和预防”Kyobu Geka。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
斉藤 憲: "ヘパリンコ-ティングチュ-ブとロ-ラポンプによる補助循環の臨床" 人工臓器. 19. 160-163 (1990)
Ken Saito:“使用肝素涂层管和滚子泵的临床辅助循环”人工器官。19. 160-163 (1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A Saito et al: "Clinical results of mechanical support using heparin-coated tube and roller pump system" Jpn J Artif Organs. 19 :. 160-163, (1990)
A Saito 等人:“使用肝素涂层管和滚子泵系统进行机械支持的临床结果”Jpn J Artif Organs。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EGUCHI Shoji其他文献

EGUCHI Shoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EGUCHI Shoji', 18)}}的其他基金

Developement of Novel Synthetic Blocks with Unique Structure and Their Application to Molecular Design of Bioactive Molecules
具有独特结构的新型合成嵌段的开发及其在生物活性分子分子设计中的应用
  • 批准号:
    07555285
  • 财政年份:
    1995
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of new immunosuppressive methods for organ transplantation targetting recognition of antigen and adhesive molecule
以抗原和粘附分子识别为目标的器官移植免疫抑制新方法的开发
  • 批准号:
    06454399
  • 财政年份:
    1994
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
SYNTHETIC DESIGN OF FUNCTIONAL HETEROPOLYCYCLES AND THEIR APPLICATION
功能性杂多环的合成设计及其应用
  • 批准号:
    04403017
  • 财政年份:
    1992
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Development of Novel Organic Fine Chemicals based on Polycycles
基于多环的新型有机精细化学品的开发
  • 批准号:
    02555174
  • 财政年份:
    1990
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似海外基金

Smart, wearable artificial lung system
智能、可穿戴式人工肺系统
  • 批准号:
    10558842
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
CELLMEMBRANE: Development of delignified nanocellulose based gas transfer scaffold membrane for artificial lung applications
CELLMEMBRANE:开发用于人工肺应用的脱木质素纳米纤维素基气体传输支架膜
  • 批准号:
    10093284
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
    EU-Funded
3D Printed Microfluidic Artificial Lung for Veteran Rehabilitation
用于退伍军人康复的 3D 打印微流控人工肺
  • 批准号:
    10629531
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Optimizing biocompatibilities of an artificial lung in a setting of a long-term pulmonary artery-left atrium (PA-LA) extracorporeal circulation system
优化长期肺动脉-左心房 (PA-LA) 体外循环系统中人工肺的生物相容性
  • 批准号:
    23H03768
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Evaluation of the Effect of Commercial Processing on Artificial Lung Zwitterionic Coatings
商业加工对人工肺两性离子涂层效果的评估
  • 批准号:
    9909574
  • 财政年份:
    2020
  • 资助金额:
    $ 4.35万
  • 项目类别:
Automated control of artificial lung systems to meet patient metabolic needs
自动控制人工肺系统以满足患者代谢需求
  • 批准号:
    10043828
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
Development of Artificial Lung Surfactant into Functional Fluorine Hybridization
功能性氟杂化人工肺表面活性剂的开发
  • 批准号:
    19K07036
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Human-scale microfluidic artificial lung
人体规模微流控人工肺
  • 批准号:
    10355523
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
Automated control of artificial lung systems to meet patient metabolic needs
自动控制人工肺系统以满足患者代谢需求
  • 批准号:
    10663779
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
Automated control of artificial lung systems to meet patient metabolic needs
自动控制人工肺系统以满足患者代谢需求
  • 批准号:
    10268182
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了